These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7191569)

  • 1. Effects of apomorphine on escape performance and activity in developing rat pups treated with 6-hydroxydopamine (6-OHDA).
    Lipton SV; McGough JP; Shaywitz BA
    Pharmacol Biochem Behav; 1980 Sep; 13(3):371-7. PubMed ID: 7191569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bromocriptine in developing rat pups after 6-hydroxydopamine.
    Shaywitz BA; Lipton SV; Teicher MH; Cohen DJ; Anderson GM; Batter DK; Young JG
    Pharmacol Biochem Behav; 1981 Sep; 15(3):443-8. PubMed ID: 6794039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.
    Shaywitz BA; Teicher MH; Cohen DJ; Anderson GM; Young JG; Levitt P
    Psychopharmacology (Berl); 1984; 82(1-2):73-7. PubMed ID: 6420833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 6-hydroxydopamine on habituation of activity in the developing rat pup.
    Shaywitz BA; Gordon JW; Klopper JH; Zelterman DA
    Pharmacol Biochem Behav; 1977 Apr; 6(4):391-6. PubMed ID: 882577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups.
    Concannon JT; Braughler JM; Schechter MD
    Pharmacol Biochem Behav; 1983 Apr; 18(4):477-82. PubMed ID: 6306694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
    Carter CJ; Pycock CJ
    Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P; Robbins TW
    Neuropharmacology; 1985 Jan; 24(1):25-31. PubMed ID: 3920545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of apomorphine on appetitive conditioning in 6-hydroxydopamine treated rat pups.
    Weldon DA; Wool RS; Teicher MH; Shaywitz BA; Cohen DJ; Anderson GM
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1281-4. PubMed ID: 6819587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.
    Kelly PH; Seviour PW; Iversen SD
    Brain Res; 1975 Sep; 94(3):507-22. PubMed ID: 1171714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-field behavior in dopamine-depleted rat pups and their mothers.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1983 Feb; 18(2):285-7. PubMed ID: 6403951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIF-1 attenuates apomorphine stereotypies in adult rats after neonatal 6-hydroxydopamine.
    Kostrzewa RM; White TG; Zadina JE; Kastin AJ
    Eur J Pharmacol; 1989 Apr; 163(1):33-42. PubMed ID: 2568266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of apomorphine in 6-hydroxydopamine-treated and aged rats.
    Schechter MD; Concannon JT
    Psychopharmacology (Berl); 1984; 83(1):99-103. PubMed ID: 6429708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic administration of food colorings on activity levels and cognitive performance in developing rat pups treated with 6-hydroxydopamine.
    Shaywitz BA; Goldenring JR; Wool RS
    Neurobehav Toxicol; 1979; 1(1):41-7. PubMed ID: 551301
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of amphetamine isomers to decrease hyperactivity in developing rats.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.